Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Avinash Pilar"'
Autor:
Sarbani Ghosh-Laskar, Avinash Pilar, Carlton Johnny, Kumar Prabhash, Amit Joshi, Jai Prakash Agarwal, Tejpal Gupta, Ashwini Budrukkar, Vedang Murthy, Monali Swain, Vanita Noronha, Vijay Maruthi Patil, Prathamesh Pai, Deepa Nair, Devendra Arvind Chaukar, Shivakumar Thiagarajan, Gouri Pantvaidya, Anuja Deshmukh, Pankaj Chaturvedi, Sudhir Nair, Anil D'Cruz
Publikováno v:
World Journal of Otorhinolaryngology-Head and Neck Surgery, Vol 6, Iss 1, Pp 25-33 (2020)
Objective: To evaluate the survival outcomes for a cohort of nasopharyngeal cancer with intracranial extension (ICE) treated with induction chemotherapy (ICT) followed by chemo-intensity-modulated radiotherapy (CTRT) at a tertiary cancer center. Meth
Externí odkaz:
https://doaj.org/article/ba739c50965e4465be6202a0af6e97c5
Coronavirus Disease 2019’s (COVID-19’s) Silver Lining—Through the Eyes of Radiation Oncology Fellows
Autor:
Avinash Pilar, MD, Samuel Bergeron Gravel, MD, Jennifer Croke, MD, Hany Soliman, MD, Peter Chung, MD, Rebecca K.S. Wong, MB ChB
Publikováno v:
Advances in Radiation Oncology, Vol 6, Iss 1, Pp 100527- (2021)
Purpose: The coronavirus disease 2019 (COVID-19) pandemic has propelled health care workers to the front lines against the pandemic. In addition to anxiety related to infection risks, trainees have the additional burden of learning and career plannin
Externí odkaz:
https://doaj.org/article/9dc12a9370b64f1aace1401182ffbf43
Publikováno v:
Journal of Contemporary Brachytherapy, Vol 9, Iss 5, Pp 466-471 (2017)
Purpose: To report an innovative technique of interstitial brachytherapy developed for treatment of orbital soft tissue tumors. Material and methods : A 4-month-old child diagnosed with rhabdomyosarcoma of orbit was treated with multiagent chemothe
Externí odkaz:
https://doaj.org/article/cbd7bf9f39e4494f8b0747f084d337b6
Autor:
Sagar A. Patel, Ting Martin Ma, Jessica K. Wong, Bradley J. Stish, Robert T. Dess, Avinash Pilar, Chandana Reddy, Trude B. Wedde, Wolfgang A. Lilleby, Ryan Fiano, Gregory S. Merrick, Richard G. Stock, D. Jeffrey Demanes, Brian J. Moran, Phuoc T. Tran, Daniel J. Krauss, Eyad I. Abu-Isa, Thomas M. Pisansky, C. Richard Choo, Daniel Y. Song, Stephen Greco, Curtiland Deville, Theodore L. DeWeese, Derya Tilki, Jay P. Ciezki, R. Jeffrey Karnes, Nicholas G. Nickols, Matthew B. Rettig, Felix Y. Feng, Alejandro Berlin, Jonathan D. Tward, Brian J. Davis, Robert E. Reiter, Paul C. Boutros, Tahmineh Romero, Eric M. Horwitz, Rahul D. Tendulkar, Michael L. Steinberg, Daniel E. Spratt, Michael Xiang, Amar U. Kishan
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 115:645-653
Very-high-risk (VHR) prostate cancer (PC) is an aggressive subgroup with high risk of distant disease progression. Systemic treatment intensification with abiraterone or docetaxel reduces PC-specific mortality (PCSM) and distant metastasis (DM) in me
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::13301f04ee3b29c70d7c09ab1809fdab
https://doi.org/10.1016/j.ijrobp.2022.09.075
https://doi.org/10.1016/j.ijrobp.2022.09.075
Publikováno v:
Current Otorhinolaryngology Reports. 10:68-84
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0164701d9acfc973e916f2682a048f71
https://doi.org/10.1007/s40136-021-00382-2
https://doi.org/10.1007/s40136-021-00382-2
Autor:
Sudeep Gupta, Dheera Aravindakshan, Lavanya Gurram, TS Shylasree, Amita Maheswari, Sabheen Bushra, Vinod Hande, Supriya Chopra, Jaya Ghosh, Palak Popat, John Paul, Nilesh Sable, Yogesh Ghadi, Umesh Mahantshetty, Avinash Pilar
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 111:826-834
Purpose A prospective phase 2 study was conducted to evaluate the feasibility and safety of single-application multifractionated (SA-MF), high-dose-rate (HDR), image guided adaptive brachytherapy (IGABT) for cervical cancer. Methods and Materials Pat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d09608b8d2fcd334001baaaf9e0a3fe4
https://doi.org/10.1016/j.ijrobp.2021.06.014
https://doi.org/10.1016/j.ijrobp.2021.06.014
Autor:
Amar U. Kishan, Alison Steigler, James W. Denham, Almudena Zapatero, Araceli Guerrero, David Joseph, Xavier Maldonado, Jessica K. Wong, Bradley J. Stish, Robert T. Dess, Avinash Pilar, Chandana Reddy, Trude B. Wedde, Wolfgang A. Lilleby, Ryan Fiano, Gregory S. Merrick, Richard G. Stock, D. Jeffrey Demanes, Brian J. Moran, Phuoc T. Tran, Santiago Martin, Rafael Martinez-Monge, Daniel J. Krauss, Eyad I. Abu-Isa, Thomas M. Pisansky, C. Richard Choo, Daniel Y. Song, Stephen Greco, Curtiland Deville, Todd McNutt, Theodore L. DeWeese, Ashley E. Ross, Jay P. Ciezki, Derya Tilki, R. Jeffrey Karnes, Jeffrey J. Tosoian, Nicholas G. Nickols, Prashant Bhat, David Shabsovich, Jesus E. Juarez, Tommy Jiang, T. Martin Ma, Michael Xiang, Rebecca Philipson, Albert Chang, Patrick A. Kupelian, Matthew B. Rettig, Felix Y. Feng, Alejandro Berlin, Jonathan D. Tward, Brian J. Davis, Robert E. Reiter, Michael L. Steinberg, David Elashoff, Paul C. Boutros, Eric M. Horwitz, Rahul D. Tendulkar, Daniel E. Spratt, Tahmineh Romero
Publikováno v:
JAMA oncology, vol 8, iss 3
JAMA Oncology
JAMA Oncology
Key Points Question What is the optimal minimum duration of androgen deprivation therapy (ADT) when treating high-risk prostate cancer with high-dose radiotherapy? Findings This patient-level cohort study of 3 cohorts found a significant interaction
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7bf4397cad9de2f66c9946476bffe693
https://escholarship.org/uc/item/9m28n0vg
https://escholarship.org/uc/item/9m28n0vg
Autor:
Eyad Abu-Isa, Albert J. Chang, Wolfgang Lilleby, Jeffrey J. Tosoian, Robert E. Reiter, Brian J. Moran, Robert T. Dess, Trude B. Wedde, Theodore L. DeWeese, D. Jeffrey Demanes, Patrick A. Kupelian, Todd McNutt, Ridwan Alam, Prashant Bhat, Tahmineh Romero, Santiago Martin, Daniel E. Spratt, Thomas M. Pisansky, Nicholas G. Nickols, Giovanni Motterle, Rafael Martínez-Monge, J.K. Wong, Gregory S. Merrick, Derya Tilki, Matthew Rettig, R. Jeffrey Karnes, Jesus E. Juarez, Michael L. Steinberg, Phuoc T. Tran, Hartwig Huland, Bradley J. Stish, Eric M. Horwitz, David Elashoff, Danny Y. Song, Bruce J. Trock, Alejandro Berlin, Chandana A. Reddy, David Shabsovich, Daniel J. Krauss, Brian J. Davis, Eric A. Klein, Michelle H. Braccioforte, Curtiland Deville, Rahul D. Tendulkar, Richard G. Stock, Natalie Chong, Paul C. Boutros, Jay P. Ciezki, Jonathan D. Tward, Ryan Fiano, Rebecca Levin-Epstein, Zeyad Schwen, Richard Choo, Ashley E. Ross, Avinash Pilar, Anthony V. D'Amico, Amar U. Kishan, Stephen Greco
Publikováno v:
JAMA Network Open
Key Points Question Are external beam radiotherapy, with or without brachytherapy boost, or radical prostatectomy associated with differences in prostate cancer–specific mortality or distant metastasis outcomes in patients with high-risk prostate c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::83931bffc35ba528f0951d3d49ede14a
http://europepmc.org/articles/PMC8251338
http://europepmc.org/articles/PMC8251338
Coronavirus Disease 2019’s (COVID-19’s) Silver Lining—Through the Eyes of Radiation Oncology Fellows
Autor:
Jennifer Croke, Avinash Pilar, Hany Soliman, Samuel Bergeron Gravel, Peter Chung, Rebecca Wong
Publikováno v:
Advances in Radiation Oncology
Advances in Radiation Oncology, Vol 6, Iss 1, Pp 100527-(2021)
Advances in Radiation Oncology, Vol 6, Iss 1, Pp 100527-(2021)
Purpose The COVID-19 pandemic has propelled health care workers (HCW) to the frontlines against the pandemic. In addition to the anxiety related to infection risks, trainees have the additional burden of learning and career planning while providing c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cd238f61b53f9e2d37cc0b09b9f96afe
Autor:
Michael Xiang, Ting Martin Ma, Ricky Savjani, Erqi L. Pollom, R. Jeffrey Karnes, Tristan Grogan, Jessica K. Wong, Giovanni Motterle, Jeffrey J. Tosoian, Bruce J. Trock, Eric A. Klein, Bradley J. Stish, Robert T. Dess, Daniel E. Spratt, Avinash Pilar, Chandana Reddy, Rebecca Levin-Epstein, Trude B. Wedde, Wolfgang A. Lilleby, Ryan Fiano, Gregory S. Merrick, Richard G. Stock, D. Jeffrey Demanes, Brian J. Moran, Hartwig Huland, Phuoc T. Tran, Santiago Martin, Rafael Martinez-Monge, Daniel J. Krauss, Eyad I. Abu-Isa, Ridwan Alam, Zeyad Schwen, Thomas M. Pisansky, C. Richard Choo, Daniel Y. Song, Stephen Greco, Curtiland Deville, Todd McNutt, Theodore L. DeWeese, Ashley E. Ross, Jay P. Ciezki, Paul C. Boutros, Nicholas G. Nickols, Prashant Bhat, David Shabsovich, Jesus E. Juarez, Natalie Chong, Patrick A. Kupelian, Matthew B. Rettig, Nicholas G. Zaorsky, Alejandro Berlin, Jonathan D. Tward, Brian J. Davis, Robert E. Reiter, Michael L. Steinberg, David Elashoff, Eric M. Horwitz, Rahul D. Tendulkar, Derya Tilki, Johannes Czernin, Andrei Gafita, Tahmineh Romero, Jeremie Calais, Amar U. Kishan
Publikováno v:
JAMA network open, vol 4, iss 12
JAMA Network Open
JAMA Network Open
Key Points Question Is previously occult, nonlocalized (regional or metastatic) disease detected on prostate-specific membrane antigen (PSMA) positron emission tomography/computed tomography (PET/CT) associated with clinically significant outcomes in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8e95f186ecaeba3347f4e647f86b2b30
https://doi.org/10.1001/jamanetworkopen.2021.38550
https://doi.org/10.1001/jamanetworkopen.2021.38550